These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8405053)

  • 1. In vivo administration of major histocompatibility complex class I-specific peptides from influenza virus induces specific cytotoxic T cell hyporesponsiveness.
    Müllbacher A; Tha Hla R
    Eur J Immunol; 1993 Oct; 23(10):2526-31. PubMed ID: 8405053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific epitope-induced conversion of CD8+ memory cells into effector cytotoxic T lymphocytes in vitro: presentation of peptide antigen by CD8+ T cells.
    Kos FJ; Müllbacher A
    Eur J Immunol; 1992 Jun; 22(6):1595-601. PubMed ID: 1376266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus.
    Gao XM; Liew FY; Tite JP
    J Immunol; 1989 Nov; 143(9):3007-14. PubMed ID: 2478631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment of alloreactive cytotoxic T lymphocytes by an antigenic peptide.
    Staerz UD; Zepp F; Schmid R; Hill M; Rothbard J
    Eur J Immunol; 1989 Dec; 19(12):2191-6. PubMed ID: 2481586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against lethal viral infection by vaccination with nonimmunodominant peptides.
    Oukka M; Manuguerra JC; Livaditis N; Tourdot S; Riche N; Vergnon I; Cordopatis P; Kosmatopoulos K
    J Immunol; 1996 Oct; 157(7):3039-45. PubMed ID: 8816413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of primary anti-viral cytotoxic T cells by in vitro stimulation with short synthetic peptide and interleukin-7.
    Kos FJ; Müllbacher A
    Eur J Immunol; 1992 Dec; 22(12):3183-5. PubMed ID: 1446709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonimmunodominant nucleoprotein-derived peptide is presented by influenza A virus-infected H-2b cells.
    Oukka M; Riché N; Kosmatopoulos K
    J Immunol; 1994 May; 152(10):4843-51. PubMed ID: 8176207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral hemagglutinin augments peptide-specific cytotoxic T cell responses.
    Ertel C; Millar NS; Emmerson PT; Schirrmacher V; von Hoegen P
    Eur J Immunol; 1993 Oct; 23(10):2592-6. PubMed ID: 8405059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dominant Th epitope in influenza nucleoprotein. Analysis of the fine specificity and functional repertoire of T cells recognizing a single determinant.
    Gao XM; Liew FY; Tite JP
    J Immunol; 1990 Apr; 144(7):2730-7. PubMed ID: 1690775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prominent usage of V beta 8.3 T cells in the H-2Db-restricted response to an influenza A virus nucleoprotein epitope.
    Deckhut AM; Allan W; McMickle A; Eichelberger M; Blackman MA; Doherty PC; Woodland DL
    J Immunol; 1993 Sep; 151(5):2658-66. PubMed ID: 7689611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection.
    Cole GA; Hogg TL; Coppola MA; Woodland DL
    J Immunol; 1997 May; 158(9):4301-9. PubMed ID: 9126992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides.
    Zhou X; Abdel Motal UM; Berg L; Jondal M
    Eur J Immunol; 1992 Dec; 22(12):3085-90. PubMed ID: 1446701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactive cytotoxic T cells recognize MHC class I antigen without peptide specificity.
    Müllbacher A; Hill AB; Blanden RV; Cowden WB; King NJ; Hla RT
    J Immunol; 1991 Sep; 147(6):1765-72. PubMed ID: 1890303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
    J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells.
    Vasilakos JP; Michael JG
    J Immunol; 1993 Mar; 150(6):2346-55. PubMed ID: 8095512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM; Turner RV; Biddison WE; Coligan JE
    J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells.
    Tamminen WL; Wraith D; Barber BH
    Eur J Immunol; 1987 Jul; 17(7):999-1006. PubMed ID: 3497045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide.
    Billetta R; Filaci G; Zanetti M
    Eur J Immunol; 1995 Mar; 25(3):776-83. PubMed ID: 7705408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition between unrelated peptides recognized by H-2-Kd restricted T cells.
    Pala P; Bodmer HC; Pemberton RM; Cerottini JC; Maryanski JL; Askonas BA
    J Immunol; 1988 Oct; 141(7):2289-94. PubMed ID: 2459204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.